Method used for detecting serum miRNA of patients with cancer based on short nucleotide chain connection

A short nucleotide and chain connection technology, which is applied in biochemical equipment and methods, microbiological determination/inspection, etc., to achieve the effect of simple operation, accurate and reliable detection results, and high specificity

Active Publication Date: 2017-08-29
深圳市展行生物有限公司
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The purpose of the present invention is to provide a method for detecting serum miRNA in cancer patients based on short nucleotide chain connection, the detection result is accurate and reliable, the...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method used for detecting serum miRNA of patients with cancer based on short nucleotide chain connection
  • Method used for detecting serum miRNA of patients with cancer based on short nucleotide chain connection
  • Method used for detecting serum miRNA of patients with cancer based on short nucleotide chain connection

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment 1

[0032]A method for detecting serum miRNA in cancer patients based on short nucleotide chain ligation, the establishment and optimization of high-throughput SOL-based technology for detecting serum miRNA: pretreatment of serum samples, and capture sequence, nucleic acid probe 1, nucleic acid Probe 2, signal amplification sequence hybridization, and then use SA-HRP to catalyze the chemiluminescent substrate solution to generate strong fluorescence, and determine the expression level of target miRNA in serum by detecting the fluorescence intensity; systematically optimize serum processing time, nucleic acid hybridization temperature, signal Amplify the number of Biotin on the sequence and other conditions, and establish a new method for miRNA detection with strong specificity, accurate and reliable results, and easy operation. miRNA; at the same time, using this miRNA detection method to detect miR-16 and miR-21 in the serum samples of 20 cases of healthy controls and 34 cases of ...

specific Embodiment 2

[0033] A method based on short nucleotide chain ligation to detect serum miRNA in cancer patients, using SOL technology to detect specific miRNA markers in serum for early diagnosis of lung cancer: using the new method of SOL detection combined with well-explored serum pretreatment methods, Two miRNAs, miR-16 and miR-21, were detected in the serum samples of 20 healthy controls and 34 NSCLC patients with different stages, ages and genders; miR-16 with relatively stable expression was used as an internal reference substance, and miR-21, which was specifically highly expressed in the serum of NSCLC patients, was used as a miRNA marker. ) detected miR-16 and miR-21 in the collected serum samples by fluorescent quantitative PCR, and the Ct value detected by miR-21 was normalized with the Ct value of internal reference miR-16, and miR-21 was compared with internal reference miR Multiples of -16 are represented by 2-ΔCt, see Table 1-2.

[0034] Table 1 Real-time quantitative PCR de...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method used for detecting serum miRNA of patients with cancer based on short nucleotide chain connection. According to the method, specific recognition and cutting of unpaired single strand nucleic acids and double-stranded nucleic acids with mismatched bases are carried out, mismatching and partial complementation of hybridization of a nucleic acid probe with target miRNA are detected, fluorescence is generated via enzymatic reaction of horse radish peroxidase combined on the nucleic acid probe with a chemiluminescent substrate, rapid amplification of detection signals is realized, and the target miRNA content is determined based on fluorescence intensity. The detection results are accurate; operation is simple and convenient; cost is low; detection throughput is high; and nucleic acid extraction or amplification is not needed.

Description

technical field [0001] The invention relates to the technical field of cancer medical diagnosis, in particular to a method for detecting serum miRNA of cancer patients based on short nucleotide chain connection. Background technique [0002] MicroRNA (miRNA) is a class of evolutionarily conserved endogenous non-protein-coding RNA molecules, about 20 to 24 nucleotides in length, capable of recognizing specific target messenger RNA (messager RNA, mRNA), and post-transcriptional level negatively regulated genes. miRNAs negatively regulate target genes by cutting or inhibiting specific mRNAs, and are widely involved in the regulation of individual development, cell apoptosis, proliferation, differentiation and other life activities. Disruption of miRNAs can affect tumorigenesis if miRNAs target tumor suppressor genes or oncogenes. Since more than half of miRNA genes are located in tumor-associated genomic regions or vulnerable sites, abnormally expressed miRNAs are closely rel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/68
CPCC12Q1/682C12Q1/6834C12Q2525/207C12Q2563/131
Inventor 李富荣凌凯李聪蒋太峰卫志坚戴蘡璎
Owner 深圳市展行生物有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap